+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Lung Cancer"

Interventional Oncology Devices Market Report 2025 - Product Thumbnail Image

Interventional Oncology Devices Market Report 2025

  • Report
  • March 2025
  • 250 Pages
  • Global
From
Oncology Biomarkers Market Report 2025 - Product Thumbnail Image

Oncology Biomarkers Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Clinical Nutrition for Cancer Care Global Market Report 2024 - Product Thumbnail Image

Clinical Nutrition for Cancer Care Global Market Report 2024

  • Report
  • August 2024
  • 175 Pages
  • Global
From
From
From
From
From
From
From
Prostate Cancer - Competitive landscape, 2024 - Product Thumbnail Image

Prostate Cancer - Competitive landscape, 2024

  • Clinical Trials
  • November 2024
  • 450 Pages
  • Global
From
From
From
From
From
Loading Indicator

Lung cancer is a type of cancer that originates in the lungs. It is the leading cause of cancer-related death worldwide. Oncology is the branch of medicine that deals with the diagnosis, treatment, and prevention of cancer. Lung cancer is one of the most common types of cancer treated by oncologists. Treatment options for lung cancer include surgery, chemotherapy, radiation therapy, and targeted therapy. The lung cancer market is a rapidly growing segment of the oncology market. It is driven by the increasing prevalence of lung cancer, advances in treatment options, and the increasing availability of targeted therapies. The market is expected to continue to grow in the coming years due to the increasing demand for better treatments and the development of new therapies. Some companies in the lung cancer market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more